enGene Therapeutics Inc.
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ENGN and other ETFs, options, and stocks.About ENGN
enGene Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in developing gene therapies. It is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.
ENGN Key Statistics
Stock Snapshot
As of today, enGene Therapeutics Inc.(ENGN) shares are valued at $1.66. The company's market cap stands at 115.56M, with a P/E ratio of -0.76.
On 2026-05-15, enGene Therapeutics Inc.(ENGN) stock traded between a low of $1.63 and a high of $1.76. Shares are currently priced at $1.66, which is +2.2% above the low and -5.6% below the high.
The enGene Therapeutics Inc.(ENGN)'s current trading volume is 2.75M, compared to an average daily volume of 6.49M.
In the last year, enGene Therapeutics Inc.(ENGN) shares hit a 52-week high of $12.25 and a 52-week low of $1.40.
In the last year, enGene Therapeutics Inc.(ENGN) shares hit a 52-week high of $12.25 and a 52-week low of $1.40.
Analyst ratings
62%
of 13 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.